{"filing":{"accession_number":"0001193125-26-288414","cik":"0001612042","ticker":"ASND","company_name":"Ascendis Pharma A/S","form":"6-K","filing_date":"2026-06-29","report_date":null,"primary_document":"d22299d6k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1612042/000119312526288414/d22299d6k.htm"},"events":[{"id":14606,"run_id":13015,"accession_number":"0001193125-26-288414","anchor_item_number":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"summary":"The 6-K discloses the closing of a warrant exercise window resulting in the issuance of 177,267 ordinary shares at an average price of approximately USD $121.57 per share, increasing share capital by nominal DKK 177,267. This represents a dilutive equity issuance triggered by warrant exercises, which is material to shareholders as it increases the share count and dilutes existing ownership. The disclosure of specific share count, pricing, and capital increase aligns with dilutive_issuance classification.","company_name":"Ascendis Pharma A/S","ticker":"ASND","filing_date":"2026-06-29","form":"6-K","submitted_at":null,"items":null}],"classifications":[{"id":12086,"accession_number":"0001193125-26-288414","item_number":null,"item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"The 6-K discloses the closing of a warrant exercise window resulting in the issuance of 177,267 ordinary shares at an average price of approximately USD $121.57 per share, increasing share capital by nominal DKK 177,267. This represents a dilutive equity issuance triggered by warrant exercises, which is material to shareholders as it increases the share count and dilutes existing ownership. The disclosure of specific share count, pricing, and capital increase aligns with dilutive_issuance classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-06-29T20:07:37.695762+00:00","company_name":"Ascendis Pharma A/S","ticker":"ASND","filing_date":"2026-06-29"}]}